InfiCure Bio Aktiebolag

ABBankrupt

Org 5590083803Other research and experimental development on natural sciences and engineering · NACE 7219Est. 20150 employees

Overview Financials People & ownership Related companies

InfiCure Bio Aktiebolag is a Swedish AB, operating in the Annan naturvetenskaplig och teknisk forskning och utveckling sector. Incorporated in 2015, the company has 0 employees and reported revenue of SEK 2,3M in its latest annual filing.

Revenue 2022

SEK 2,3M

+84% vs 2021

EBITDA margin

-70.8%

+50% vs 2021

Equity ratio

-12.8%

Financial strength

Net profit 2022

SEK -1,7M

+49% vs 2021

EBITDA — year on year

SEK millions

Key figures

Annual report 2022

Revenue	SEK 2,3M	+84%
EBITDA	SEK -1,6M	+50%
Net profit	SEK -1,7M	+49%
Total assets	SEK 1,1M	+2%
Equity	SEK -139K	-1258%
Employees	0	—

Contact

Address

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of InfiCure Bio Aktiebolag?

InfiCure Bio Aktiebolag is registered with Bolagsverket / SCB under Org 5590083803.

What is the revenue of InfiCure Bio Aktiebolag?

InfiCure Bio Aktiebolag reported revenue of SEK 2,3M in 2022.

Who is the CEO of InfiCure Bio Aktiebolag?

Britta Sofia Caroline Mayans is Chief Executive Officer of InfiCure Bio Aktiebolag, in role since 2022.

Who is the chairman of InfiCure Bio Aktiebolag?

Dan Ingemar Holmberg chairs the board of InfiCure Bio Aktiebolag, in role since 2022.

InfiCure Bio Aktiebolag

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on InfiCure Bio Aktiebolag

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on InfiCure Bio Aktiebolag